The human herpesviruses HHV-6, HHV-7, and HHV-8

Viral Infections and Treatment

Volumn , Issue , 2016, Pages 659-705

  Ablashi, Dharam V ^a,b   Krueger, Gerhard R F ^c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Advanced Biotechnologies Inc   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85121534500     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14823-22     Document Type: Chapter

References (245)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234:596-601.
2. Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM, June CH. Isolation of a new herpesvirus from human CD4þ T cells. Proc Natl Acad Sci USA 1990; 87:748-752.
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994; 266:1865-1869.
4. Ablashi DV, Salahuddin SZ, Josephs SF, Imam F, Lusso P, Gallo RC, Hung C, Lemp J, Markham PD. HBLV (or HHV-6) in human cell lines. Nature 1987; 329):207.
5. Downing RG, Sewankambo N, Serwadda D, Honess R, Crawford D, Jarrett R, Griffin BE. Isolation of human lymphotropic herpesviruses from Uganda. Lancet 1987; 2):390.
6. Lopez C, Pellett P, Stewart J, Goldsmith C, Sanderlin K, Black J, Warfield D, Feorino P. Characteristics of human herpesvirus-6. J Infect Dis 1988; 157:1271-1273.
7. Berneman ZN, Gallo RC, Ablashi DV, Frenkel N, Katsafanas G, Kramarsky B, Brus I. Human herpesvirus 7 (HHV-7) strain JI: independent confirmation of HHV-7. J Infect Dis 1992; 166:690-691.
8. Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E. The spectrum of Kaposi’s sarcoma-associated herpesvirus (KSHV) or human herpesvirus 8 (HHV-8) diseases. Clin Microbiol Rev 2002; 15:436-464.
9. Ablashi D, Agut H, Berneman Z, Campadelli-Fiume G, Carrigan D, Ceccerini-Nelli L, Chandran, B, Chou S, Collandre H, Cone R, Dambaught T, Dewhurst S, DiLuca D, Foa-Tomasi L, Fleckenstein B, Frenkel N, Gallo R, Gompels U, Hall C, Jones M, Lawrence G, Martin M, Montagnier L, Neipel F, Nicholas J, Pellett P, Razzaque A, Torrelli G, Thomson B, Salahuddin S, Wyatt L, Yamanishi K. Human herpesvirus-6 strain groups: a nomenclature. Arch Virol 1993; 129:363-366.
10. Franti M, Aubin JT, De Saint-Maur G, Kosuge H, Yamanishi K, Gautheret-Dejean A, Garbarg-Chenon A, Huraux JM, Agut H. Immune reactivity of human sera to the glycoprotein B of human herpesvirus 7. J Clin Microbiol 2002; 40:44-51.
11. Thawaranantha D, Chimabutra K, Balachandra K, Warachit P, Pantuwatana S, Tanaka-Taya K, Inagi R, Kurata T, Yamanishi K. Genetic variations of human herpesvirus 7 by analysis of glycoproteins B and H, and R2- repeat regions. J Med Virol 2002; 66:370-377.
12. Hayward GS. KSHV strains: the origins and global spread of the virus. Semin Cancer Biol 1999; 9:187-199.
13. Schulz TF. KSHV (HHV8) infection. J Infect 2000; 41:125-129.
14. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S. Association of human herpesvirus 6 (HHV-6) with multiple sclerosis:increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997; 3:1394-1397.
15. Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, Pearson GR, Whitman JE. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000; 16:179-191.
16. Hirata Y, Kondo K, Yamanishi K. Human herpesvirus 6 downregulates major histocompatibility complex class I in dendritic cells. J Med Virol 2001; 65:576-583.
17. Braun DK, Dominguez G, Pellett PE. Human herpesvirus 6. Clin Microbiol Rev 1997; 10:521-567.
18. Clark DA. Human herpesvirus 6. Rev Med Virol 2000; 10:155-173.
19. Campadelli-Fiume G, Mirandola P, Menotti L. Human herpesvirus 6: an emerging pathogen. Emerg Infect Dis 1999; 5:353-366.
20. Inoue N, Dambaugh TR, Pellett PE. Molecular biology of human herpesviruses 6A and 6B. Infect Agents Dis 1994; 2:343-360.
21. Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GR, Kramarsky B, Salahuddin SZ, Gallo RC. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 1991; 184:545-552.
22. Frenkel N, Roffman E. Human herpesvirus-7. In: Fields BN, Knipe DM, Howley, PM, Chanock RM, Monath TP, Roizman B, Straus SE, eds. Fields Virology, vol 2. Philadelphia: Lippincott-Raven, 1996:2609-2622.
23. Black JB, Pellett PE. Human herpesvirus 7. Rev Med Virol 1999; 9:245-262.
24. Neipel F, Albrecht JC, Ensser A, Huang YQ, Lee IJ, Friedman-Kein AE, Fleckenstein B. Cell homologous genes in the Kaposi’s sarcoma-associated rhadinovirus human herpesvirus-8 determinants of its pathogenicity. J Virol 1997; 71:4187-4192.
25. Renne R, Langunoff M, Zhong W, Ganem D. The size and conformation of Kaposi’s sarcoma-associated herpesvirus (HHV-8) DNA in infected cells and virions. J Virol 1996; 70:8151-8154.
26. Neipel F, Fleckenstein B. The role of HHV-8 in Kaposi’s sarcoma. Semin Cancer Biol 1999; 9:151-164.
27. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999; 99:817-827.
28. Flamand L, Romerio F, Reitz MS, Gallo RC. CD4 promoter transactivation by human herpesvirus 6. J Virol 1998; 72:8797-8805.
29. Flamand L, Gosselin J, Ablashi DV, D’Addario M, Hiscott J, Menezes J. Dual effect of human herpesvirus 6 (HHV-6) on mononuclear cells:induction of IL-1a and TNFa but suppression of IL-6 synthesis. J Virol 1992; 65:5105-5110.
30. Li C, Goodrich JM, Yang X. Interferon-gamma (IFN-gamma) regulates production of IL-10 and IL-12 in human herpesvirus-6 (HHV-6)-infected monocyte/macrophage lineage. Clin Exp Immunol 1997; 109:421-425.
31. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 1995; 85:1263-1271.
32. Salahuddin SZ, Kelley AS, Krueger GRF, Josephs SF, Gupta S, Ablashi DV. Human herpesvirus-6 (HHV-6) in diseases. Clin Diagn Virol 1993; 1:81-100.
33. Krueger GRF, Klueppelberg U, Hoffmann A, Ablashi DV. Clinical correlates of infection with human herpesvirus-6. In Vivo 1994; 8:457-486.
34. Yoshikawa T, Asano Y. Central nervous system complications in human herpesvirus-6 infection. Brain Dev 2000; 22:307-314.
35. Gies M, Jalali Z, Wagner M, Krueger GRF. Modulation of nuclear factor kappa B (NF-kB) activity in human herpesvirus-6 (HHV-6) infection and its sequellae for cell function: effects of antisense DNA treatment. Rev Med Hosp Gen Mexico 1998; 61:218-225.
36. Eichler F, Krueger GRF. Effects of non-specific immunostimulants (Echinacin, isoprinosine and thymus factor) on the infection and antigen expression in herpesvirus-6 exposed human lymphoid cells. In Vivo 1994; 8:565-576.
37. Schonnebeck M, Krueger GRF, Braun M, Fischer M, Koch B, Ablashi DV, Balachandran N. Human herpesvirus 6 infection may predispose cells for superinfection by other viruses. In Vivo 1991; 5:255-265.
38. Gosselin J, Flamand L, D’Addario M, Hiscott J, Stefanescu I, Ablashi DV, Gallo RC, Menezes J. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. J Immunol 1992; 149:181-187.
39. Murphy PM. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2001; 2:116-122.
40. Arena A, Liberto MC, Iannello D, Capozza AB, Foca A. Altered cytokine production after human herpesvirus type 6 infection. New Microbiol 1999; 22:293-300.
41. Vignoli M, Furlini G, Re MC, Ramazzotti E, La Placa M. Medulation of VD4, CXCR-4, and CCR-5 makes human hematopoietic progenitor cell lines infected with human herpesvirus-6 susceptible to human immunodeficiency virus type 1. J Hematother Stem Cell Res 2000; 9:39-45.
42. Lusso P, Malnati M, De Maria A, Balotta C, De Rocco SE, Markham PD, Gallo RC. Productive infection of CD4þ and CD8þ mature human T cell populations and clones by human herpesvirus 6. Transcriptional downregulation of CD3. J Immunol 1991; 147:685-691.
43. Farber I, Wutzler P. FC receptors induced by human herpesvirus-6. Acta Virol 1991; 35):400.
44. Hasegawa A, Yasukawa M, Sakai I, Fujita S. Transcriptional downregulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YYI with c-myc in human herpesvirus-6 infected cells. J Immunol 2001; 166:1125-1131.
45. Kirn E, Krueger E, Boehmer S, Klussmann JP, Krueger GRF. In vivo cytobiological effects of human herpesvirus 6 and 7: immunohistological monitoring of apoptosis, differentiation and cell proliferation. Anticancer Res 1997; 17: 4623-4632.
46. Milne RS, Mattick C, Nicholson L, Devaraj P, Alcami A, Gompels UA. RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J Immunol 2000; 164:2396-2404.
47. Campadelli-Fiume G. Virus receptor arrays, CD46 and human herpesvirus 6. Trends Microbiol 2000; 8:436-438.
48. Loveland B. Protein reviews on the web: http://www.ncbi.nlm.nih.gov/ PROW/guide/2027814670g.htm
49. Fox JD, Briggs M, Ward T, Tedder RS. Human herpesvirus-6 in salivary glands. Lancet 1990; I:590-593.
50. Krueger GRF, Wassermann K, DeClerck LS, Stevens WJ, Bourgeois N, Ablashi DV, Josephs SF, Balachandran N. Latent herpesvirus-6 in salivary and bronchial glands. Lancet 1990; II:1255-1256.
51. Ablashi DV, Krueger GRF, Salahuddin SZ, eds. Human Herpesvirus-6. Elsevier, Amsterdam, 1992; Perspect Med Virol 4:1-341.
52. Hall CB, Long CE, Schnabel KC, Caserta MT, McIntire KM, Costanzo MA, Knott A, Dewhurst S, Insel RA, Epstein LG Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994; 331:432-438.
53. Wierbitzky S, Ratzmann GW, Bruns R, Wierbitzky H. Reactivation in children of juvenile chronic arthritis and chronic iridocyclitis associated with human herpesvirus-6. Pediatr Grenzgeb 1993; 31:203-205.
54. Patnaik M, Komaroff AL, Conley E, Ojo-Amaize EA, Peter JB. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis 1995; 172:1364-1367.
55. Wagner M, Krueger GRF, Ablashi DV, Whitman JE. Chronic fatigue syndrome (CFS): a critical evaluation of testing for active human herpesvirus-6 (HHV-6) infection: review of data from 107 cases. J Chron Fatigue Syndr 1996; 2:3-16.
56. Reeves WC, Stamey FR, Black JB, Mawle AC, Stewart JA, Pellett PE. Human herpesvirus 6 and 7 in chronic fatigue syndrome: a case-control study. Clin Infect Dis 2000; 31:48-52.
57. Enbom M, Linde A, Evengard B. No evidence of active infection with human herpesvirus 6 (HHV-6) or HHV-8 in chronic fatigue syndrome. J Clin Microbiol 2000; 38):2457.
58. Prezioso PJ, Cangiarelle J, Lee M, Nuovo GJ, Barkowsky W, Orlow SJ, Greco MA. Fatal disseminated infection with human herpesvirus-6. J Pediatr 1992; 120:921-923.
59. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; I:1065-1067.
60. Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T, Kajita Y, Ozaki T. Clinical features of infants with primary herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 1994; 93:104-108.
61. Lasch J, Klussmann JP, Krueger GRF. Die humanen Herpesviren 6 und 7. Hautarzt 1996; 47:341-350.
62. Sumiyoshi Y, Kikuchi M, Ohshima K, Yoneda S, Kobari S, Takeshita M, Eizuru Y, Minamishima Y. Human herpesvirus-6 genomes in histiocytic necrotizing lymphadenitis (Kikuchi’s disease) and other forms of lymphadenitis. Am J Clin Pathol 1993; 99:609-614.
63. Krueger GRF, Huetter ML, Rojo J, Romero M, Cruz-Ortiz H. Human herpesvirus-4 (EBV) and HHV-6 in Hodgkin’s and Kikuchi’s diseases and their relationship to proliferation and apoptosis. Anticancer Res 2001; 21:2155-2162.
64. Steeper TA, Horwitz CA, Ablashi DV, Salahuddin SZ, Saxinger C, Saltzman R, Schwartz B. The spectrum of clinical and laboratory findings resulting from human herpes virus-6 (HHV-6) in patients with mononucleosis- like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol 1990; 93:766-783.
65. Akashi K, Eizu Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, Kikuchi M, Niho Y, Minamishima Y. Brief report: severe infectious mononucleosislike syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993; 329:168-171.
66. Bertram G, Dreiner N, Krueger GRF, Ramon A, Ablashi DV, Salahuddin SZ, Balachandran N. Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis. In Vivo 1991; 5:271-280.
67. Luppi M, Marasca R, Barozzi P, Artusi T, Torelli G. Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffinembedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Leukemia Res 1993; 17:1003-1011.
68. Daibata M, Ido E, Murakami K, Kuzume T, Kubonishi I, Taguchi H, Miyoshi I. Angioimmunoblastic lymphadenopathy with disseminated human herpersvirus 6 infection in a patient with acute myeloblastic leukemia. Leukemia 1997; 11:882-895.
69. Sugita K, Kurumada H, Eguchi M, Furukawa T. Human herpesvirus 6 infection associated with hemophagocytic syndrome. Acta Haematol 1995; 93:108-109.
70. Tanaka H, Nishimura T, Hakui M, Sugimoto H, Tanaka-Taya K, Yamanishi K. Human herpesvirus 6-associated hematophagocytic syndrome in a healthy adult. Emerging Infect Dis 2002; 8:87-88.
71. Leahy MA, Krejci SM, Friednash M, Stockert SS, Wilson H, Huff JC, Weston WL, Brice SL. Human herpesvirus 6 is present in lesions of Langerhans cell histiocytosis. J Invest Dermatol 1993; 101:642-645.
72. Torelli G, Marasca R, Luppi M, Ferrari S, Narni F, Mariano MT, Federico M, Ceccherini-Nelli L, Bendinelli M, Montagnani G, Montorsi M, Artusi T. Human herpesvirus-6 in human lymphomas: identification of specific sequences in Hodgkin’s lymphomas by polymerase chain reaction. Blood 1991; 77:2251-2258.
73. Di Luca D, Dolcetti R, Mirandola P, de Re V, Secchiero P, Carbone A, Boiocchi M, Cassai E Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral blood lymphocytes and lymphoproliferative disorders. J Infect Dis 1994; 70:211-215.
74. Krueger GRF, Manak M, Bourgeaois N, Ablashi DV, Salahuddin SZ, Josephs SF, Buchbinder A, Gallo RC, Berthold F, Tesch H. Persistent active herpesvirus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma. Anticancer Res 1989; 9:1457-1476.
75. Razzaque A, Francillon Y, Jilly PN, Varicchio F Detection of human herpesvirus 6 sequences in lymphoma tissues by immunohistochemistry and polymerase chain reaction. Cancer Lett 1996; 106:221-226.
76. Bandobashi K, Daibata M, Kamioka M, Tanaka Y, Kubonishi I, Taguchi H, Ohtsuki Y, Miyoshi I. Human herpesvirus-6 (HHV-6)- positive Burkitt’s lymphoma: establishment of a novel cell line infected with HHV-6. Blood 1997; 90:1200-1207.
77. Braun DK, Pellet PE, Hanson CA. Presence and expression of human herpesvirus 6 in peripheral blood mononuclear cells of S100-positive T cell chronic lymphoproliferative disease. J Infect Dis 1995; 171:1351-1355.
78. Lin WC, Moore JO, Mann KP, Traweek ST, Smith C. Post transplant CD8þ gammadelta T-cell lymphoma associated with human herpesvirus-6 infection. Leuk Lymphoma 1999; 33:377-384.
79. Hallas C, Neipel F, Huettner C, Schreiner D, Fleckenstein B, Muller-Hermelink HK. Presence of human herpesvirus type 6 in sporadic lymphoproliferative disorders. Diagn Mol Pathol 1996; 5:166-172.
80. Luppi M, Barozzi P, Garber R, Maiorana A, Bonacorsi G, Artusi T, Trovato R, Marasca R, Torelli G. Expression of human herpesvirus 6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol 1998; 153:815-823.
81. Razzaque A. Oncogenic potential of human herpesvirus-6 DNA. Oncogene 1990; 5:1365-1370.
82. Thompson J, Choudhuri S, Kashanchi F, Doniger J, Berneman Z, Frenkel N, Rosenthal LJ. A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1. Oncogene 1994; 9:1167-1175.
83. Krueger GRF, Ferrer Argote V. A unifying concept of viral immunopathogenesis of proliferative and aproliferative diseases. In Vivo 1994; 8:493-500.
84. Carrigan DR, Knox KK. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 1994; 84:3307-3310.
85. Wang FZ, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88:3615-3620.
86. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996; 124:1065-1071.
87. Isomura H, Yamada M, Yoshida M, Tanaka H, Kitamura T, Oda M, Nii S, Seino Y. Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J Med Virol 1997; 52:406-412.
88. Penchansky L, Jordan JA. Transient erythroblastopenia of childhood associated with human herpesvirus type 6, variant B. Am J Clin Pathol 1997; 108:127-132.
89. Wang FZ, Linde A, Dahl H, Ljungman P. Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24:1201-1206.
90. Rosenfeld CS, Rybka WB, Weinbaum D, Carrigan DR, Knox KK, Andrews DF, Shadduck RK. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995; 23:626-629.
91. Lau YL, Peiris M, Chan GCF, Chan ACL, Chiu D, Ha SY. Primary herpesvirus 6 infection transmitted from donor to recipient through bone marrow infusion. Bone Marrow Transplant 1998; 21:1063-1066.
92. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolf P, Oebrt G. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin Infect Dis 1996; 22:171-173.
93. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, Grange MJ, Grossin M, Navratil E, Crickx B, Belaich S. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive hemophagocytic syndrome. Br J Dermatol 1997; 137:605-608.
94. Tohyama M, Yahata Y, Inagi R, Urano Y, Yamanishi K, Hashimoto K. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998; 134:1113-1117.
95. Conilleau V, Dompmartin A, Verneuil L, Michel M, Leroy D. Hypersensitivity syndrome due to 2 anticonvulsant drugs. Contact Dermatitis 1999; 41:141-144.
96. Descamps V, Valance A, Edlinger C, Fillet AM, Grosssin M, Lebrun-Vignes B, Belaich S, Crickx B. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001; 137:301-304.
97. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998; 134:1108-1112.
98. Mizukawa Y, Shiohara T. Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: with emphasis on EB virus, human herpesvirus 6 and hepatitis C virus. J Dermatol Sci 2000; 22:169-180.
99. Lusso P. Target cells for infectio. In: Ablashi DV, Krieger GRF, Salahuddin SZ, eds. Human Herpesvirus 6. Amsterdam: Elsevier, 1992; pp 25-36.
100. Cuomo L, Trivedi P, Cardillo MR, Gagliardi FM, Vecchione A, Caruso R, Calogero A, Frati L, Faggioni A, Ragona G. Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 2001; 63:45-51.
101. Caserta MT, Hall CB, Schnabel K, McIntire K, Long C, Costanzo M, Dewhurst S, Insel R, Epstein LG. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994; 170:1586-1589.
102. Wilborn F, Schmidt CA, Brinkmann V, Jendroschka K, Ottle H, Siegert W. A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol 1994; 49:213-214.
103. Knox KK, Carrigan DR. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Def Syndr Human Retrovir 1995; 9:69-73.
104. Wagner M, Muller-Berghaus J, Schroeder R, Sollberg S, Luka J, Leyssens N, Schneider B, Krueger GRF. Human herpesvirus-6 (HHV-6)-associated necrotizing encephalitis in Griscelli’s syndrome. J Med Virol 1997; 53:306-312.
105. Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis. Ann Neurol 2000; 47:306-313.
106. Studahl M, Hagberg L, Rekabdar E, Bergstrom T. Herpesvirus DNA detection in cerebral spinal fluid: differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses. Scand J Infect Dis 2000; 32:237-248.
107. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer GC. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92:7440-7444.
108. Enbohm M. Human herpesvirus 6 in the pathogenesis of multiple sclerosis. APMIS 2001; 109:401-411.
109. Rotola A, DiLuca D, Cassai E, Ricotta D, Giulio A, Turano A, Caruso A, Muneretto C. Human herpesvirus 6 infects and replicates in aortic endothelium. J Clin Microbiol 2000; 38:3135-3136.
110. Wu CA, Shanley JD. Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6. J Gen Virol 1998; 79:1247-1256.
111. Drago F, Rampini P, Brusati C, Rebora A. Leukocytoclastic vasculitis in a patient with HHV-6 infection. Acta Derm Venerol 1999;80: 68.
112. Hagiwara K, Yoshida T, Komura H, Kishi F, Kajii T. Isolation of human herpesvirus-6 from an infant with Kawasaki’s disease. Eur J Pediatr 1993; 152):176.
113. Luka J, Gubin J, Afflerbach C, Carson SD, Krueger GRF. Detection of human herpesvirus-6 (HHV-6) genome by in situ PCR in tissues from Kawasaki disease and in coronary arteries of transplanted hearts. Third Int Conf Modern Methods in Analytical Morphology, Atlantic City, NJ, June 1995 (Abstract).
114. Fukae S, Ashizawa N, Morikawa S, Yano K. A fatal case of fulminant myocarditis with human herpesvirus-6 infection. Intern Med 2000; 39:632-636.
115. Cone RW, Hackman RC, Meei-Li WH, Bowden RA, Meyers JD, Metcalf M, Zeh J, Ashley R, Corey L. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993; 329:156-161.
116. Knox KK, Pietryga D, Harrington DJ. Franciosi R, Carrigan DR. Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant. Clin Infect Dis 1995; 20:406-413.
117. Aita K, Jin Y, Irie H, Takahashi I, Kobori K, Nakasato Y, Kodama H, Yanagawa Y, Yoshikawa T, Shiga J. Are there histopathological characteristics particular to fulminant hepatic failure caused by human herpesvirus-6 infection? A case report and discussion. Hum Pathol 2001; 32:887-889.
118. Lusso P, Ablashi DV, Luka J. Interaction between HHV-6 and other viruses. In: Ablashi DV, Krueger GRF, Salahuddin SZ, eds. Human Herpesvirus 6. Amsterdam: Elsevier, 1992, pp 121-133.
119. Flamand L, Stefanescu I, Ablashi DV, Menezes J. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 1993; 67:6768-6777.
120. al-Khaldi N, Watson AR, Harris A, Irving WL. Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient. Pediatr Nephrol 1994; 8:349-350.
121. Chen M, Wang H, Woodworth CD, Lusso P, Berneman Z, Kingma D, Delgado G, DiPaolo JA. Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma. Am J Pathol 1994: 145:1509-1516.
122. Lusso P, Garzino-Demo A, Crowley RW, Malnati MS. Infection of g/d T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med 1995; 181:1303-1310.
123. Ablashi DV, Bernbaum J, DiPaolo JA: Human herpesvirus 6 as a copathogen. Trends Immunobiol 1995; 3: 324-326.
124. Cuomo L, Trivedi P, de Grazia U, Colagero A, D’Onofrio M, Yang W, Frati L, Faggioini A, Rymo L, Ragona G. Upregulation of Epstein-Barr virusencoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells. J Med Virol 1998; 55:219-226.
125. Singh VK, Lin SX, Yang VC. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol 1998; 89:105-108.
126. Furukawa M, Yasukawa M, Yakushijin Y, Fujita S. Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4þ T cells. J Immunol 1994; 152:5768-5775.
127. Ablashi DV, Handy M, Bernbaum J, Chatlynne LG, Lapps W, Kramarsky B, Berneman ZN, Komaroff AL, Whitman JE. Propagation and characterization of human herpesvirus-7 (HHV-7) isolates in a continuous Tlymphoblastoid cell line (SupT1). J Virol Methods 1998; 73:123-140.
128. Asano Y, Suga S, Yoshikawa T, Yazaki T, Uchikawa T. Clinical features and viral excretion in an infant with primary human herpesvirus 7 infection. Pediatrics 1995; 95:187-190.
129. Suga S, Yoshikawa T, Nagai T, Asano Y. Clinical features and virological findings in children with primary human herpesvirus 7 infection. Pediatrics 1997; 99:1-5.
130. Huang LM, Lee CY, Liu MY, Lee PI. Primary infections of human herpesvirus-7 and herpesvirus-6: a comparative, longitudinal study up to 6 years of age. Acta Pediatr 1997; 86:604-608.
131. Bruns R, Muller CE, Wierbitzky SK, Neipel F, Jager G. Clinical presentations of infection by the human herpesvirus-7 (HHV-7). Pediatr Hematol Oncol 2000; 17:247-252.
132. Atedzoe BN, Menezes J, D’Addario M, Xu J, Ongradi J, Ahmad A. Modulatory effects of human herpesvirus-7 on cytokine synthesis and cell proliferation in human peripheral blood mononuclear cell cultures. J Leukoc Biol 1999; 66:822-828.
133. Atedzoe BN, Ahmad A, Menezes J. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J Immunol 1997; 159:4966-4972.
134. Secchiero P, Gibellini D, Flamand L, Robuffo I, Marchisio M, Capitani S, Gallo RC, Zauli G. Human herpesvirus 7 induces the down-regulation of CD4 antigen in lymphoid T cells without affecting p56lck levels. J Immunol 1997; 159:3412-3423.
135. Secchiero P, Bertolaso L, Casareto L, Gibellini D, Vitale M, Bemis K, Aleotti A, Capitani S, Franchini G, Gallo RC, Zauli G. Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(þ) T cells. Blood 1998; 92:1685-1696.
136. Secchiero P, Zella D, Barabitskaja O, Reitz MS, Capitani S, Gallo RC, Zauli G. Progressive and persistent downregulation of surface CXCR4 in CD4(þ) T cells infected with human herpesvirus 7. Blood 1998; 92:4521-4528.
137. Yasukawa M, Hasegawa A, Sakai I, Ohminami H, Arai J, Kaneko S, Yakushin Y, Maeyama K, Nakashima H, Arakaki R, Fujita S. Downregulation of CXCR4 by human herpesvirus 6 (HHV-6) AND HHV-7. J Immunol 1999; 162:5417-5422.
138. Secchiero P, Mirandola P, Zella D, Celeghini C, Gonelli A, Vitale M, Capitani S, Zauli G. Human herpesvirus 7 induces the functional upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-medulation in CD4(þ) T cells. Blood 2001; 98:2472-2481
139. Chiu HH, Lee CY, Lee PI, Lin KH, Huang LM. Mononucleosis syndrome and coincidental human herpesvirus-7 and Epstein-Barr virus infection. Arch Dis Child 1998; 78:479-480.
140. Tanaka-Taya K, Kondo T, Nakagawa N, Inagi R, Miyoshi H, Sunagawa T, Okada S, Yamanishi K. Reactivation of human herpesvirus 6 by infection of human herpesvirus 7. J Med Virol 2000; 60:284-289.
141. Chapenko S, Folkmane I, Tomsone V, Amerika D, Rozentals R, Murovska M. Co-infection of two beta-herpesviruses (CMV and HHV-7) as an increased risk factor for “CMV disease” in patients undergoing renal transplantation. Clin Transplant 2000; 14:486-492.
142. Chapenko S, Folkmane I, Tomsone V, Kozireva S, Bicans J, Amerika D, Rozentals R, Morivska M. Infection of b-herpesviruses (CMV, HHV-6, HHV-7): role in postrenal transplantation complications. Transplant Proc 2001; 33:2463-2464.
143. Lusso P, Secchiero P, Crowley RW, Garzino-Demo A, Berneman ZN, Gallo RC. CD4 is a critical component of the receptor for human herpesvirus 7:interference with human immunodeficiency virus. Proc Natl Acad Sci USA 1994; 91:3872-3876.
144. Yasukawa M, Inoue Y, Sada E, Yakushijn Y, Furukawa M, Fujita S. CD4 downmodulation by ganglioside and phorbol ester inhibits human herpesvirus 7 infection. J Gen Virol 1995; 76:2381-2385.
145. Secchiero P, Sun D, De Vico AL, Crowley RW, Reitz MS, Zauli G, Lusso P, Gallo RC. Role of extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans. J Virol 1997; 71:4571-4580.
146. Mirandola P, Secchiero P, Pierpaoli S, Visani G, Zamai L, Vitale M, Capitani S, Zauli G. Infection of CD34(þ) hematopoietic progenitor cells by human herpesvirus 7 (HHV-7). Blood 2000; 96:126-131.
147. Zhang Y, de Bolle L, Aquaro S, van Lommel A, De Clerq E, Schols D. Productive infection of primary macrophages with human herpesvirus 7. J Virol 2001; 75:10511-10514.
148. Yadav M, Nambiar S, Khoo SP, Yaacob HB. Detection of human herpesvirus 7 in salivary glands. Arch Oral Biol 1997; 42:559-567.
149. Gonelli A, Boccia S, Boni M, Pozzoli A, Rizzo C, Querzoli P, Cassai E, Di Luca D. Human herpesvirus 7 is latent in gastric mucosa. J Med Virol 2001; 63:277-283.
150. Chan PK, Ng HK, Cheung JL, Ng KC, Cheng AF. Prevalence and distribution of human herpesvirus 7 in normal brain. J Med Virol 2000; 62:345-348.
151. Sairenji T, Yamanishi K, Tachibana Y, Bertoni G, Kurata T. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology 1995; 38:269-273.
152. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K. Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr 1994; 125:1-5.
153. Ueda K, Kusuhara K, Okada K, Miyazaki C, Hidaka Y, Tokugawa K, Yamanishi K. Primary human herpesvirus 7 infection and exanthem subitum. Pediatr Infect Dis J 1994; 13:167-168.
154. Chua KB, AbuBakar S. Isolation and identification of human herpesvirus 7 from an infant with exanthem subitum. Med J Malaysia 1998; 53:296-301.
155. Komatsu H, Inui A, Koike Y, Fujisawa T, Suga S, Ishizaki T, Yamada A, Kikuta H. Detection of human herpesvirus 7 DNA in the cerebrospinal fluid of a child with exanthem subitum. Pediatr Int 2000; 42:103-105.
156. Kirby B, Al-Jiffri O, Cooper RJ, Corbitt G, Klapper PE, Griffiths CE. Investigation of cytomegalovirus and human herpesviruses 6 and 7 as possible causative antigens in psoriasis. Acta Derm Venereol 2000; 80:404-406.
157. Offidani A, Pritelli E, Simonetti O, Cellini A, Giornetta L, Bossi G. Pityriasis rosea associated with herpesvirus 7 DNA. J Eur Acad Dermatol Venereol 2000; 14:313-314.
158. Kempf W, Adams V, Hleinhans M, Burg G, Panizzon RG, Campadelli-Fiume G, Nestle FO. Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol 1999; 135:1070-1072.
159. Oyama Y, Midorikawa S, Satoh K, Sugawara T, Imai H. Adult onset human herpesvirus (HHV)-7 infection presented necrotizing lymphadenitis and Sweet’s syndrome. Nippon Naika Gakkai Zasshi 2001; 90:2082-2084.
160. Kempf W, Kadin ME, Kutzner H, Lord CL, Burg G, Letvin NL, Koralnim IJ. Lymphomatoid papulosis and human herpesviruses-a PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol 2001; 28:29-33.
161. Kempf W, Muller B, Maurer R, Adams C, Campadelli-Fiume G. Increased expression of human herpesvirus 7 in lymphoid organs of AIDS patients. J Clin Virol 2000; 16:193-201.
162. Yamada M. Human herpesvirus 6 and 7: effects on hematopoiesis and mode of transmission. Jpn J Infect Dis 2001; 54:47-54.
163. Gautheret-Dejean A, Dejean O, Vastel L, Kerboull M, Aubin JT, Franti M, Agut H. Human herpesvirus-6 and human herpesvirus-7 in the bone marrow from healthy subjects. Transplantation 2000; 27:1722-1723
164. Kawa-Ha K, Tanaka K, Inoue M, Sakata N, Okada S, Kurata T, Mukai T, Yamanishi K. Isolation of human herpesvirus 7 from a child with symptoms mimicking chronic Epstein-Barr virus infection. Br J Haematol 1993; 84:545-548.
165. Secchiero P, Bonino LD, Lusso P, Abele MC, Reato G, Kerim S, Palestro G, Zauli G, Valente G. Human herpesvirus type 7 in Hodgkin’s disease. Br J Haematol 1998; 101:492-499.
166. Berneman ZN, Torelli G, Luppi G, Jarrett RF. Absence of direct causative role for human herpesvirus 7 in human lymphoma and review of human herpesvirus 6 in human malignancy. Ann Hematol 1998; 77:275-278.
167. Nagore E, Ledesma E, Collado C, Oliver V, Perez-Perez A, Aliaga A. Detection of Epstein-Barr virus and human herpesvirus 7 and 8 in primary cutaneous T- and B-cell lymphomas. Br J Dermatol 2000; 143:320-323.
168. Schmidt CA, Oettle H, Peng R, Binder T, Wilborn F, Huhn D, Siegert W, Herbst H. Presence of human b- and g-herpes virus DNA in Hodgkin’s disease. Leukemia Res 2000; 24:865-870.
169. Daibata M, Komatsu T, Taguchi H Human herpesviruses in primary ocular lymphoma. Leuk Lymphoma 2000; 37:361-365.
170. Torigoe S, Koide W, Yamada M, Miyashiro E, Tanaka-Taya K, Yamanishi K:. Human herpesvirus 7 infection associated with central nervous system manifestations. J Pediatr 1996; 129:301-305.
171. Clark DA, Kidd IM, Collingham KE, Tarlow M, Ayeni T, Riordan A, Griffith PD, Emery VC, Pillay D. Diagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reaction. Arch Dis Child 1997; 77:42-45.
172. Teach SJ, Wallace HL, Evans MJ, Duffner PK, Hay J, Faden HS. Human herpesvirus types 6 and 7 and febrile seizures. Pediatr Neurol 1999; 21:699-703.
173. van den Berg JS, van Zeiji JH, Rotteveel JJ, Melchers WJ, Gabreels FJ, Galama JM. Neuroinvasion by human herpesvirus type 7 in a case of exanthem subitum with severe neurologic manifestations. Neurology 1999; 52:1077-1079.
174. Pohl-Koppe A, Blay M, Jager G, Weiss M. Human herpesvirus type 7 DNA in the cerebrospinal fluid of children with central nervous system disease. Eur J Pediatr 2001; 160:351-358.
175. Broccolo F, luliano R, Careddu AM, Trovato R, Lico S, Blanc PL, Mazotta F, Ceccherini-Nelli L. Detection of lymphotropic herpesvirus DNA by polymerase chain reaction in cerebrospinal fluid of AIDS patients with neurological disease. Acta Virol 2000; 44:137-143.
176. Sugaya N, Yoshikawa T, Miura M, Ishizuka T, Kawakami C, Asano Y Influenza encephalopathy associated with infection with human herpesvirus 6 and/or herpesvirus 7. Clin Infect Dis 2002; 34:461-466.
177. Rotola A, Caselli E, Cassai E, Tola MR, Granieri E, Luca DD Novel human herpesviruses and multiple sclerosis. J Neurovirol 2000; 6(suppl 2):S88-S91.
178. Tomsone V, Logina I, Millers A, Chapenko S, Kozireva S, Murovska M. Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system. J Neurovirol 2001; 7:564-569.
179. Paul KS, Ng HK, Cheng AFB. Detection of human herpesvirus 6 and 7 genomic sequences in brain tumours. J Clin Pathol 1999; 52:620-623.
180. Dockrell DH, Paya CV. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 2001; 11:23-36.
181. Ihira M, Yoshikawa T, Suzuki K, Ohashi M, Suga S, Asonuma K, Tanaka K, Asano Y. Correlation between human herpesvirus 6 and 7 infections after living related liver transplantation. Microbiol Immunol 2001; 45:225-232.
182. Miyoshi H, Tanaka-Taya K, Hara J, Fujisaki H, Matsuda Y, Ohta H, Osugi Y, Okada S, Yamanishi K. Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation. Bone Marrow Transplant 2001; 27:1065-1070.
183. Emery VC. Human herpesvirus 6 and 7 in solid organ transplant recipients. Clin Infect Dis 2001; 32:1357-1360.
184. Folkmane I, Chapenko D, Amerika J, Bicans M, Murovska M, Rosentals R. b-Herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression. Transplant Proc 2001; 33:2384-2385.
185. Ross DJ, Chan RCK, Kubak B, Laks H, Nichols WS. Bronchiolitis obliterans with organizing pneumonia: possible association with human herpesvirus-7 infection after lung transplantation. Transplant Proc 2001; 33:2603-2606.
186. Wyatt LS, Frenkel N. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 1992; 66:3206-3209.
187. Hidaka Y, Liu Y, Yamamoto M, Mori R, Miyazaki C, Kusuhara K, Okada K, Ueda K. Frequent isolation of human herpesvirus 7 from saliva samples. J Med Virol 1993; 40:343-346.
188. Di Luca D, Mirandola P, Ravaioli T, Dolcetti R, Frigatti A, Bovenzi P, Sighinolfi L, Monini P, Cassai E. Human herpesvirus 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 1995; 45:462-468.
189. Gersch CB. Nachweis und Bedeutung herpesviraler Antigene in der menschlichen Speicheldruese bei entzuenddlichen und neoplastischen Erkrankungen. MD Thesis at University of Cologne, Cologne, 2002, pp 1-96.
190. Hashida T, Komura E, Yoshida M, Otsuka T, Hibi S, Imashuku S, Imashuku S, Ishizaki T, Yamada A, Suga S. Hepatitis in association with human herpesvirus-7 infection. Pediatrics 1995; 96:783-785.
191. Torigoe S, Tabata N, Yamada M, Koide W, Ito M, Ihara T, Kamiya H. Prolonged viremia and immune response to human herpesvirus 7 in an infant with liver dysfunction. Pediatrics 1997; 98:398-400.
192. Burns JC, Newburger JW, Sundell R, Wyatt LS, Frenkel N. Seroprevalence of human herpesvirus 7 in patients with Kawasaki’s disease. Pediatr Infect Dis 1994; 13:168-169.
193. Foreman KE, Friborg J, Kong WP, Woffendin C, Polverini J, Nickoloff BJ, Nabel GJ. Propagation of human herpesvirus from AIDS-associated Kaposi’s sarcoma. N Engl J Med 1997; 336:163-171.
194. Flore O, Rafii S, Ely S, O’Leary JJ, Hyjek M, Cesarman E. Transformation of primary human endothelial cells by Kaposi’s sarcoma-associated herpesvirus. Nature 1998; 394:588-592.
195. Cannon JS, Ciufo D, Hawkins AL, Griffin CA, Borowitz MJ, Hayward GW, Ambinder RF. A new primary effusion lymphoma derived cell line yields highly infectious Kaposi’s sarcoma herpesvirus containing supernatant. J Virol 2000; 74:10187-10193.
196. Wu FY, Ahn JH, Alcender DJ, Jang WJ, Xian J, Hayward D, Hayward G. Origin-independent assembly of Kaposi’s sarcoma-associated herpesvirus replication compartments in transient co-transfection assays and association with the ORFK8 protein and cellular PML. J Virol 2001; 75:1487-1506.
197. Muralidhar SA, Pumphrey A, Huasani M, Sadaie R, Azumi N, Brady JN, Medvezcky P, Rosenthal LJ. Identification of kaposin (ORF K12) a human herpesvirus-8 (Kaposi’s sarcoma-associated herpesvirus-8) oncogenes. J Acquir Immune Defic Syndr Retrovirol 1998; 17:A27.
198. Birkmann AK, Mahr K Ensser A, Yaguboglu S, Titgemeyer F, Fleckenstein B, Neipel F. Cell surface heparan sulfate is a receptor for human herpesvirus-8 and interacts with envelope glycoprotein K8.1. J Virol 2001; 75:11583-11593.
199. Boschoff C, Weiss RA. Kaposi’s sarcoma-associated herpesvirus. Adv Cancer Res 1998; 75:57-86.
200. Chang Y, Moore PS. Kaposi’s sarcoma-associated herpesvirus and its role in KS. Infect Agents Dis 1996; 5:215-222.
201. International Agency for Research on Cancer. Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus-8. IARC Monograph 70. Lyons, France: IARC, 1997, pp 375-492.
202. Kaposi M. Idiopatisches multiples pigment sarkom der Haut. Arch Dermatol Syphilis 1872; 4:265-273.
203. Gill PS, Tsai YC, Rao P, Spruck CH, Zheng T, Harrington WA, Cheung T, Nathwani B, Jones PA. Evidence of multi-clonality in multicentric Kaposi’s sarcoma. Proc Natl Acad Sci USA 1998; 95:8257-8261.
204. Knowles D, Inghirami MG, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasm of uncertain lineage demon- strates their B-cell derivation and the possible pathogenic role of the Epstein-Barr virus. Blood 1989; 73:792-799.
205. Carbone A, Gloghini A, Vaccher E, Zagonel V, Pastore C, Dalla-Palma P, Branz F, Saglio G, Volpe R, Tirelli U, Guidano G. Kaposi’s sarcomaassociated herpesvirus DNA sequences in AIDS-related and AIDSunrelated lymphomatous effusion. Br J Hematol 1996; 94:533-543.
206. Said JW, Tasaka T, Takeuchi S, Asou H, deVos S, Baker J, Hanson G, Cesarman E, Knowles DM, Koeffler HP. Primary effusion lymphoma in women: report of two cases of Kaposi’s sarcoma-herpesvirus-associated effusion-based lymphoma in immune-deficiency virus-negative women. Blood 1996; 88:3124-3128.
207. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MA, Said J, Knowles DM. Primary infusion lymphoma-a distinct clinico-pahologic entity associated with Kaposi’s sarcoma-associated herpesvirus. Blood 1996; 88:645-656.
208. Engles EA, Rosenberg A, Frisch M, Gosdert JJ. Cancers associated with Kaposi’s sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma. Br J Cancer 2001; 85:1298-1303.
209. Leach CT, Franz C, Head DR, Gao J, McClain KL, Cohen M, Campbell AB, Pollock H, Murphy SB, Johnson HB. Human herpesvirus-8 (HHV-8) associated with small non-cleaved cell lymphoma in a child with AIDS. Am J Hematol 1999; 60:215-221.
210. Soulier J. Groller L, Okesenhandler E, Cacoub P, Cazays-Hatem D, Bahindet P, d’Agay MF, Clauvel JP, Raphael M, Dergos L, Sigau X. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 1995; 86:1275-1280.
211. Samoszuk M, Ramzi E, Ravel J. Disseminated persistent lymphoid hyperplasia containing Epstein-Barr virus and clonal rearrangements of DNA. Diagn Mol Pathol 1993; 2:57-60.
212. Hanson CA, Frizzera G, Patton DF, Peterson BA, McClain KL, Gajl-Peczalska KJ, Kersey JH. Clonal rearrangement for immunoglobulin and Tcell receptor genes in systemic Castleman’s disease: association with Epstein-Barr virus. Am J Pathol 1988; 131:84-91.
213. Parravieini C, Corbellino CM, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y. Expression of a virus derived cytokine, KSHV vIL-6 in HIV sero-negative Castleman’s disease. Am J Pathol 1997; 151:1517-1522.
214. Dupin NA, Marcelin AG, Callvez V, Andr E. Absence of a link between human herpesvirus-8 and pemphigus. Br J Hematol 1999; 141:159-160.
215. Francis G, Mouquel C, Calvez V. Human herpesvirus-8 and renal transplantation. N Engl J Med 1999; 340):1045.
216. Yadav M, Umamaheswari S, Ablashi D. Antibody reactivity with two strains of human herpesvirus-6 in Malaysians. J Med Virol 1991; 33:236-239.
217. Straus SE. Epstein-Barr virus and human herpesvirus type 6. In: Galasso GJ, Whitley RJ, Merigan TC, eds. Antiviral Agents and Viral Diseases of Man. New York: Raven Press, 1990, pp 647-668.
218. Okuno T, Takahashi K, Balachandra K, Shiraki K, Yamanishi K, Takahashi M, Baba K. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989; 27:651-653.
219. Cone RW, Huang ML, Hackman RC, Corey L. Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol 1996; 34:877-881.
220. Hall CB, Caserta MT, Schnabel KC, Long C, Epstein LG, Insel RA, Dewhurst S. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998; 26:132-137.
221. Levine PH, Ablashi DV. An etiologic perspective of the new herpesviruses:HHV-7 and HHV-8. Infect Med 1999; 16:24-33.
222. Tanaka-Taya K, Kondo T, Mukai T, Miyoshi H, Yamamoto Y, Okada S, Yamanishi K. Seroepidemiological study of human herpesvirus-6 and -7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. J Med Virol 1996; 48:88-94.
223. Wilborn F, Schmidt CA, Lorenz F, Peng R, Gelderblom H, Huhn D, Siegert W. Human herpesvirus type 7 in blood donors: detection by the polymerase chain reaction. J Med Virol 1995; 47:65-69.
224. Ablashi DV, Berneman ZN, Kramarsky B, Whitman, JE, Asano Y, Pearson GR. Human herpesvirus-7 (HHV-7): current status. Clin Diag Virol 1995; 4:1-13.
225. Chatlynne LG, Ablashi DV. Sero-epidemiology of Kaposi’s sarcomaassociated herpesvirus (KSHV). Semin Cancer Biol 1999; 9:175-185.
226. Ablashi DV, Chatlynne LG, Cooper HC, Thomas DA, Yadav M, Norhanom AW, et al. Sero-prevalence of human herpesvirus-8 (HHV-8) in countries of southeast Asia, compared to the United States, the Caribbean and Africa. Br J Cancer 1999; 81:893-897.
227. Whitby D, Smith S, Modhew S, O’Shea S, Sabin CA, Kulase-Garam R, Boschoff C, Weiss RE, deRuiter A, Best M. Human herpesvirus-8: seroepidemiology among women and detection in the genital tract of seropositive women. J Infect Dis 1999; 179:234-236.
228. Cannon MJ, Dollard SC, Smith DK, Klein RS, Schuman P, Rich JD, Vlahoy D, Pellett PE. Blood-borne and sexual transmission of human herpesvirus-8 in women with or at risk for human immune-deficiency virus infection. N Engl J Med 2001; 344:637-643.
229. Levine PH, Jahan N, Murari P, Manak M, Jaffe ES. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis 1992; 166(2):291-295.
230. Kearns AM, Turner AJ, Taylor CE, Freeman R, Gennery AR. LightCyclerbased quantitative PCR for rapid detection of human herpesvirus 6 DNA in clinical material. J Clin Microbiol 2001; 39:3020-3021.
231. Locatelli G, Santoro F, Veglia F, Gobbi A, Lusso P, Malnati MS. Real-time quantitative PCR for human herpesvirus 6 DNA. J Clin Microbiol 2000; 38:4042-4048.
232. Van den Bosch G, Locatelli G, Geerts L, Faga G, Ieven M, Goossens H, Bottiger D, Oberg B, Lusso P, Berneman ZN. Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infection. J Clin Microbiol 2001; 39:2308-2310.
233. Mookerjee BP, Vogelsang G. Human herpesvirus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 1997; 20:905-906.
234. Streicher HZ, Hung CL, Ablashi DV, Hellman K, Saxinger C, Fullen J, Salahuddin SZ. In vitro inhibition of human herpesvirus-6 by phosphonoformate. J Virol Methods 1988; 21:301-304.
235. Williams MV. HHV-6: response to antiviral agents. In: Ablashi DV, Krueger GRF, Salahuddin SZ, eds. Human Herpesvirus-6: Epidemiology, Molecular Biology and Clinical Pathology. Amsterdam: Elsevier, 1992, pp 317-335.
236. De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 2001; 11:381-395.
237. Cattelan AM, Calabro ML, Gasperini P, Aversa SML, Zanchetta M, Meneghetti F, Rossi A, Chieco-Bianchi L. Acquired immune-deficiency syndrome-related Kaposi’s sarcoma regression after highly active anti-viral therapy: biological correlations of clinical outcome. Natl Cancer Monog 2000; 28:44-49.
238. Medvezcky MM, Horvath F, Lund T, Medvezcky PG. In vitro antiviral drug sensitivity of the Kaposi’s sarcoma-associated herpesvirus. AIDS 1997; 11:1327-1332.
239. Jones JL, Hanson L, Sworkin MS, Ward JW, Jaffe HW. Effect of antiviral therapy on recent trends in selected cancer among HIV-infected persons:adult/adolescent spectrum of HIV disease project group. J AIDS 1999; 21(suppl 1):511-517.
240. Ablashi DV, Berneman ZN, Lawyer C, Kramarsky B, Ferguson DM, Komaroff AL. Antiviral activity in vitro of kutapressin against human herpesvirus-6. In Vivo 1994; 8:581-586.
241. Strayer DR, Carter W, Straus KL, Brodsky I, Suhadolnik RJ, Ablashi DV, Henry B, Michell WM, Bastien S, Peterson D. Long-term improvements in patients with chronic fatigue syndrome treated with ampligen. J CFS 1995; 1:35-53.
242. Ablashi DV, Berneman ZN, Williams M, Strayer DR, Kramarsky B, Suhadolnik RJ, Reichenbach N, Hiltzges P, Komaroff AL. Ampligen inhibits human herpesvirus-6 in vitro. In Vivo 1994B; 8:587-591.
243. Ablashi DV, Levine PH, De Vinci C, Whitman JE Jr, Pizza G, Viza D. Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Biotherapy 1996; 9:81-86.
244. Amanishi K, De Clercq E. Selective activity of various nucleoside and nucleotide analogues against herpesvirus 6 and 7. Antivir Chem Chemother 1997; 8:24-31.
245. Reymen D, Naesens L, Balzarini J, Holy A, Dvorakova H, De Clercq E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res 1995; 28:343-357.